AMCA
BMY icon

Arthur M. Cohen & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Arthur M. Cohen & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,010
Closed -$278K – 129
2025
Q2 		$278K Buy
6,010
+2,000
+50% +$98.2K 0.05% 113
2025
Q1 		$245K Hold
4,010
– – 0.05% 115
2024
Q4 		$227K Hold
4,010
– – 0.04% 128
2024
Q3 		$212K Buy
+4,010
New +$188K 0.04% 134
2024
Q2 		– Sell
-3,990
Closed -$216K – 141
2024
Q1 		$216K Buy
+3,990
New +$203K 0.05% 126
2019
Q4 		– Sell
-3,990
Closed -$202 – 126
2019
Q3 		$202 Buy
+3,990
New +$188K 0.06% 121
2019
Q2 		– Sell
-8,745
Closed -$417K – 118
2019
Q1 		$417K Sell
8,745
-39,191
-82% -$1.95M 0.15% 79
2018
Q4 		$2.98K Hold
47,936
– – 0.95% 21
2018
Q3 		$2.98K Sell
47,936
-3,531
-7% -$210K 0.91% 21
2018
Q2 		$2.85M Buy
51,467
+140
+0.3% +$7.56K 1.08% 18
2018
Q1 		$3.15M Buy
51,327
+21,273
+71% +$1.37M 1.19% 18
2017
Q4 		$1.56K Buy
+30,054
New +$1.88M 0.43% 27
2017
Q2 		$3.22M Sell
57,197
-26,437
-32% -$1.44M 1.26% 23
2017
Q1 		$3.07M Buy
83,634
+28,380
+51% +$1.56M 1.37% 23
2016
Q4 		$3.18M Buy
+55,254
New +$3.02M 1.68% 15
2014
Q3 		$3.6M Buy
+56,397
New +$2.82M 1.67% 17

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arthur M. Cohen & Associates's BMY Position: Q3 2025 in Review

Arthur M. Cohen & Associates sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 6,010 shares — an estimated $278K sold.

Arthur M. Cohen & Associates first reported a position in BMY in Q3 2014 and held it in 16 quarters. The position peaked at $3.6M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Arthur M. Cohen & Associates reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Arthur M. Cohen & Associates sold 6,010 Bristol-Myers Squibb shares in Q3 2025, an estimated $278K.
  • Arthur M. Cohen & Associates first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 16 quarters.
  • Arthur M. Cohen & Associates's Bristol-Myers Squibb position peaked at $3.6M in Q3 2014.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Arthur M. Cohen & Associates's 13F filing for Q3 2025, filed 14 Oct 2025.